Study Data


NMR Study

Project uploaded by: Neel Sarovar
Project ID: IMP_100036
Title: NMR based human gut metabolomic profiling reveals altered metabolites associated with pulmonary and extra-pulmonary tuberculosis
Project Description: Introduction: Tuberculosis remains one of the world's deadliest infectious diseases. The pathophysiology of the two manifestations of Mycobacterium tuberculosis infection, pulmonary TB (PTB) and extrapulmonary TB (EPTB) is still not fully understood. Understanding the metabolic profile of both disease manifestations in patients is important for developing therapeutic approaches and molecular diagnosis. Objective: The current study aimed to elucidate differences in the gut metabolic profile of PTB and EPTB patients compared to healthy controls (HCs). Method: We used an untargeted approach through 1 H Nuclear Magnetic Resonance (NMR) spectroscopy to perform metabolomic profiling of stool samples from 77 TB patients [pulmonary TB (PTB, n = 33), cervical lymph node TB (CrLNTB, n =30), abdominal TB (ATB, n = 14)], and 30 HCs. Multivariate and univariate analyses were performed to identify the differential gut metabolites associated with TB patients. Results: The PTB patients had higher metabolic perturbation than EPTB patients compared to HCs. The top three significantly altered metabolites, namely valine, N-formyl-L- methionine and dimethylsulfone, were used to generate random forest model to distinguish between TB patients and HCs. The receiver operating characteristics curve analysis was used to assess the performance of the model with area under curve score of 0.831, capable to distinguish TB patients from HCs. Thus, our findings offer insights into the gut metabolome of TB patients in India and characterizes for the first time metabolic perturbations in EPTB patients. Conclusion: The study highlights the metabolic disruptions associated with PTB and EPTB patients.
Research Area: Biological Sciences
Funding Source: JC bose fellowship, ICGEB core fund, Insitute of eminence, DU.
Project Contributors: Vishal Sharma , Anoop Singh , Sonam Sharma , Mohita Gaur , Arun Kumar Malaisamy , Deepti Rawat , Anjali Yadav , Bolaji Fatai Oyeyemi , Aarushi Vasudeva , Anil Chaudhry , Ashwani Khanna , Vishal Khanna , Sheelu Lohiya , Reema Arora , Anannya Bandyopadhyay , Neel Sarovar Bhavesh, Yogendra Singh, Richa Misra

Study uploaded by: Neel Sarovar
Study ID: IMS_100030
Title: NMR based human gut metabolomic profiling reveals altered metabolites associated with pulmonary and extra-pulmonary tuberculosis
Summary: Introduction: Tuberculosis remains one of the world's deadliest infectious diseases. The pathophysiology of the two manifestations of Mycobacterium tuberculosis infection, pulmonary TB (PTB) and extrapulmonary TB (EPTB) is still not fully understood. Understanding the metabolic profile of both disease manifestations in patients is important for developing therapeutic approaches and molecular diagnosis. Objective: The current study aimed to elucidate differences in the gut metabolic profile of PTB and EPTB patients compared to healthy controls (HCs). Method: We used an untargeted approach through 1 H Nuclear Magnetic Resonance (NMR) spectroscopy to perform metabolomic profiling of stool samples from 77 TB patients [pulmonary TB (PTB, n = 33), cervical lymph node TB (CrLNTB, n =30), abdominal TB (ATB, n = 14)], and 30 HCs. Multivariate and univariate analyses were performed to identify the differential gut metabolites associated with TB patients. Results: The PTB patients had higher metabolic perturbation than EPTB patients compared to HCs. The top three significantly altered metabolites, namely valine, N-formyl-L- methionine and dimethylsulfone, were used to generate random forest model to distinguish between TB patients and HCs. The receiver operating characteristics curve analysis was used to assess the performance of the model with area under curve score of 0.831, capable to distinguish TB patients from HCs. Thus, our findings offer insights into the gut metabolome of TB patients in India and characterizes for the first time metabolic perturbations in EPTB patients. Conclusion: The study highlights the metabolic disruptions associated with PTB and EPTB patients.
Keywords: Tuberculosis, diagnosis, pulmonary TB, extra-pulmonary TB, 1H NMR spectroscopy, gut metabolites
Publication: Metabolomics
Release Date: July 22, 2025
Study Type: Nuclear Magnetic Resonance (NMR)
Data Type: Untargeted
IEC/IBSC Approval Number : 2653/RBIPMT/2019

Sr.No Sample ID Sample Name Organism Source Sample Preparation Protocol Sample Type Experimental Condition Time of treatment Variant/Variety Gender Age Replicates Storage Conditions Extraction Protocol Number of files per sample
11 IMSM_101569 Exp 82 Homo sapiens | 9606 Stool The frozen stool aliquots were thawed and ~200 mg of the sample was weighed into a sterile microcentrifuge tube. The samples were homogenized in 600μl of autoclaved Milli-Q water for 2-3 minutes before centrifugation at 15,000g for 15 minutes. 400μl of supernatant was transferred to a fresh microcentrifuge tube, and 200μl of 0.1M potassium phosphate buffer pH 7.4 in D 2 O (0.2 M of K 2 HPO 4 and KH 2 PO 4 , containing 10% (w/v) 4,4-dimethyl-4-silapentane-1- sulfonic acid (DSS), a reference compound), was added to each sample. The sample was vortexed, centrifuged, and loaded into the 5 mm NMR tube for 1 H NMR spectra acquisition. CrLN TB TB NA NA F 19 NA -80

NA

12 IMSM_101570 Exp 103 Homo sapiens | 9606 Stool The frozen stool aliquots were thawed and ~200 mg of the sample was weighed into a sterile microcentrifuge tube. The samples were homogenized in 600μl of autoclaved Milli-Q water for 2-3 minutes before centrifugation at 15,000g for 15 minutes. 400μl of supernatant was transferred to a fresh microcentrifuge tube, and 200μl of 0.1M potassium phosphate buffer pH 7.4 in D 2 O (0.2 M of K 2 HPO 4 and KH 2 PO 4 , containing 10% (w/v) 4,4-dimethyl-4-silapentane-1- sulfonic acid (DSS), a reference compound), was added to each sample. The sample was vortexed, centrifuged, and loaded into the 5 mm NMR tube for 1 H NMR spectra acquisition. CrLN TB TB NA NA M 24 NA -80

NA

13 IMSM_101571 Exp 104 Homo sapiens | 9606 Stool The frozen stool aliquots were thawed and ~200 mg of the sample was weighed into a sterile microcentrifuge tube. The samples were homogenized in 600μl of autoclaved Milli-Q water for 2-3 minutes before centrifugation at 15,000g for 15 minutes. 400μl of supernatant was transferred to a fresh microcentrifuge tube, and 200μl of 0.1M potassium phosphate buffer pH 7.4 in D 2 O (0.2 M of K 2 HPO 4 and KH 2 PO 4 , containing 10% (w/v) 4,4-dimethyl-4-silapentane-1- sulfonic acid (DSS), a reference compound), was added to each sample. The sample was vortexed, centrifuged, and loaded into the 5 mm NMR tube for 1 H NMR spectra acquisition. CrLN TB TB NA NA F 26 NA -80

NA

14 IMSM_101572 Exp 163 Homo sapiens | 9606 Stool The frozen stool aliquots were thawed and ~200 mg of the sample was weighed into a sterile microcentrifuge tube. The samples were homogenized in 600μl of autoclaved Milli-Q water for 2-3 minutes before centrifugation at 15,000g for 15 minutes. 400μl of supernatant was transferred to a fresh microcentrifuge tube, and 200μl of 0.1M potassium phosphate buffer pH 7.4 in D 2 O (0.2 M of K 2 HPO 4 and KH 2 PO 4 , containing 10% (w/v) 4,4-dimethyl-4-silapentane-1- sulfonic acid (DSS), a reference compound), was added to each sample. The sample was vortexed, centrifuged, and loaded into the 5 mm NMR tube for 1 H NMR spectra acquisition. CrLN TB TB NA NA F 20 NA -80

NA

15 IMSM_101573 Exp 198 Homo sapiens | 9606 Stool The frozen stool aliquots were thawed and ~200 mg of the sample was weighed into a sterile microcentrifuge tube. The samples were homogenized in 600μl of autoclaved Milli-Q water for 2-3 minutes before centrifugation at 15,000g for 15 minutes. 400μl of supernatant was transferred to a fresh microcentrifuge tube, and 200μl of 0.1M potassium phosphate buffer pH 7.4 in D 2 O (0.2 M of K 2 HPO 4 and KH 2 PO 4 , containing 10% (w/v) 4,4-dimethyl-4-silapentane-1- sulfonic acid (DSS), a reference compound), was added to each sample. The sample was vortexed, centrifuged, and loaded into the 5 mm NMR tube for 1 H NMR spectra acquisition. CrLN TB TB NA NA M 20 NA -80

NA

16 IMSM_101574 Exp 199 Homo sapiens | 9606 Stool The frozen stool aliquots were thawed and ~200 mg of the sample was weighed into a sterile microcentrifuge tube. The samples were homogenized in 600μl of autoclaved Milli-Q water for 2-3 minutes before centrifugation at 15,000g for 15 minutes. 400μl of supernatant was transferred to a fresh microcentrifuge tube, and 200μl of 0.1M potassium phosphate buffer pH 7.4 in D 2 O (0.2 M of K 2 HPO 4 and KH 2 PO 4 , containing 10% (w/v) 4,4-dimethyl-4-silapentane-1- sulfonic acid (DSS), a reference compound), was added to each sample. The sample was vortexed, centrifuged, and loaded into the 5 mm NMR tube for 1 H NMR spectra acquisition. CrLN TB TB NA NA F 24 NA -80

NA

17 IMSM_101575 Exp 200 Homo sapiens | 9606 Stool The frozen stool aliquots were thawed and ~200 mg of the sample was weighed into a sterile microcentrifuge tube. The samples were homogenized in 600μl of autoclaved Milli-Q water for 2-3 minutes before centrifugation at 15,000g for 15 minutes. 400μl of supernatant was transferred to a fresh microcentrifuge tube, and 200μl of 0.1M potassium phosphate buffer pH 7.4 in D 2 O (0.2 M of K 2 HPO 4 and KH 2 PO 4 , containing 10% (w/v) 4,4-dimethyl-4-silapentane-1- sulfonic acid (DSS), a reference compound), was added to each sample. The sample was vortexed, centrifuged, and loaded into the 5 mm NMR tube for 1 H NMR spectra acquisition. CrLN TB TB NA NA F 23 NA -80

NA

18 IMSM_101576 Exp 206 Homo sapiens | 9606 Stool The frozen stool aliquots were thawed and ~200 mg of the sample was weighed into a sterile microcentrifuge tube. The samples were homogenized in 600μl of autoclaved Milli-Q water for 2-3 minutes before centrifugation at 15,000g for 15 minutes. 400μl of supernatant was transferred to a fresh microcentrifuge tube, and 200μl of 0.1M potassium phosphate buffer pH 7.4 in D 2 O (0.2 M of K 2 HPO 4 and KH 2 PO 4 , containing 10% (w/v) 4,4-dimethyl-4-silapentane-1- sulfonic acid (DSS), a reference compound), was added to each sample. The sample was vortexed, centrifuged, and loaded into the 5 mm NMR tube for 1 H NMR spectra acquisition. CrLN TB TB NA NA F 27 NA -80

NA

19 IMSM_101577 Exp 209 Homo sapiens | 9606 Stool The frozen stool aliquots were thawed and ~200 mg of the sample was weighed into a sterile microcentrifuge tube. The samples were homogenized in 600μl of autoclaved Milli-Q water for 2-3 minutes before centrifugation at 15,000g for 15 minutes. 400μl of supernatant was transferred to a fresh microcentrifuge tube, and 200μl of 0.1M potassium phosphate buffer pH 7.4 in D 2 O (0.2 M of K 2 HPO 4 and KH 2 PO 4 , containing 10% (w/v) 4,4-dimethyl-4-silapentane-1- sulfonic acid (DSS), a reference compound), was added to each sample. The sample was vortexed, centrifuged, and loaded into the 5 mm NMR tube for 1 H NMR spectra acquisition. CrLN TB TB NA NA F 32 NA -80

NA

20 IMSM_101578 Exp 215 Homo sapiens | 9606 Stool The frozen stool aliquots were thawed and ~200 mg of the sample was weighed into a sterile microcentrifuge tube. The samples were homogenized in 600μl of autoclaved Milli-Q water for 2-3 minutes before centrifugation at 15,000g for 15 minutes. 400μl of supernatant was transferred to a fresh microcentrifuge tube, and 200μl of 0.1M potassium phosphate buffer pH 7.4 in D 2 O (0.2 M of K 2 HPO 4 and KH 2 PO 4 , containing 10% (w/v) 4,4-dimethyl-4-silapentane-1- sulfonic acid (DSS), a reference compound), was added to each sample. The sample was vortexed, centrifuged, and loaded into the 5 mm NMR tube for 1 H NMR spectra acquisition. CrLN TB TB NA NA M 25 NA -80

NA

Sr.No NMR Exp ID Sample Name/ID Reference Standard NMR Instrument Name NMR Instrument Type NMR Experiment Type NMR Spectrometer Frequency NMR Probe NMR Probe temperature NMR Solvent NMR tube size Data Transformation (Software/s Used)
21 IME_100824 Exp 212 / IMSM_101579 DSS Bruker Avance III 500MHz Solution NMR 1D 1H 500 5 mm triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298k D2O 5 mm NA
22 IME_100825 Exp 210 / IMSM_101580 DSS Bruker Avance III 500MHz Solution NMR 1D 1H 500 5 mm triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298k D2O 5 mm NA
23 IME_100826 Exp 216 / IMSM_101581 DSS Bruker Avance III 500MHz Solution NMR 1D 1H 500 5 mm triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298k D2O 5 mm NA
24 IME_100827 Exp 217 / IMSM_101582 DSS Bruker Avance III 500MHz Solution NMR 1D 1H 500 5 mm triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298k D2O 5 mm NA
25 IME_100828 Exp 228 / IMSM_101583 DSS Bruker Avance III 500MHz Solution NMR 1D 1H 500 5 mm triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298k D2O 5 mm NA
26 IME_100829 Exp 229 / IMSM_101584 DSS Bruker Avance III 500MHz Solution NMR 1D 1H 500 5 mm triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298k D2O 5 mm NA
27 IME_100830 Exp 230 / IMSM_101585 DSS Bruker Avance III 500MHz Solution NMR 1D 1H 500 5 mm triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298k D2O 5 mm NA
28 IME_100831 Exp 231 / IMSM_101586 DSS Bruker Avance III 500MHz Solution NMR 1D 1H 500 5 mm triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298k D2O 5 mm NA
29 IME_100832 Exp 232 / IMSM_101587 DSS Bruker Avance III 500MHz Solution NMR 1D 1H 500 5 mm triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298k D2O 5 mm NA
30 IME_100833 Exp 233 / IMSM_101588 DSS Bruker Avance III 500MHz Solution NMR 1D 1H 500 5 mm triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298k D2O 5 mm NA

Sr.No First name Last name Email Organization Designation
1 Richa Misra richamisra@svc.ac.in University of Delhi principal_investigator
2 Yogendra Singh ysinghdu@gmail.com University of Delhi co_principal_investigator
3 Neel Sarovar Bhavesh neelsb@icgeb.res.in ICGEB co_principal_investigator
4 Anannya Bandyopadhyay anannya@zoology.du.ac.in University of Delhi research_scholar
5 Reema Arora arorareema1569@gmail.com Lok Nayak Hospital research_scholar
6 Sheelu Lohiya drsheelulohiya@gmail.com Lok Nayak Hospital research_scholar
7 Vishal Khanna dr.vishalkhanna@reddif.com Lok Nayak Hospital research_scholar
8 Ashwani Khanna dr.vishalkhanna@reddif.com Lok Nayak Hospital research_scholar
9 Anil Chaudhry dranilchaudhry@gmail.com Rajan Babu Institute of Pulmonary Medicine and Tuberculosis research_scholar
10 Aarushi Vasudeva aarushi_vasudeva@yahoo.com University of Delhi research_scholar
11 Bolaji Fatai Oyeyemi bolajioyeyemi@gmail.com ICGEB research_scholar
12 Anjali Yadav anniey2411@gmail.com University of Delhi research_scholar
13 Deepti Rawat deeptirawat0397@gmail.com University of Delhi research_scholar
14 Arun Kumar Malaisamy makias191@gmail.com ICGEB research_scholar
15 Mohita Gaur m.mohitagaur@gmail.com University of Delhi research_scholar
16 Sonam Sharma sonamsharmamr@gmail.com ICGEB research_scholar
17 Anoop Singh anoop.singh.du@gmail.com University of Delhi research_scholar
18 Vishal Sharma s.vishalzoology@gmail.com University of Delhi research_scholar

Sr.No ftprun ID NMR Exp ID NMR Data Files
91 IMR_101493 IME_100894 220.zip
92 IMR_101494 IME_100895 221.zip
93 IMR_101495 IME_100896 226.zip
94 IMR_101496 IME_100897 227.zip
95 IMR_101497 IME_100898 219.zip
96 IMR_101498 IME_100899 218.zip
97 IMR_101499 IME_100900 235.zip
98 IMR_101500 IME_100901 236.zip
99 IMR_101501 IME_100902 237.zip
100 IMR_101502 IME_100903 238.zip